Document Report Card

Basic Information

ID: ALA4665759

Journal: Bioorg Med Chem Lett

Title: Discovery of substituted 3H-pyrido[2,3-d]pyrimidin-4-ones as potent, biased, and orally bioavailable sst2 agonist.

Authors: Zhao J,Chen Z,Kusnetzow AK,Nguyen J,Rico-Bautista E,Tan H,Betz SF,Struthers RS,Zhu Y

Abstract: The discovery of a novel 3H-pyrido[2,3-d]pyrimidin-4-one series as potent and biased sst2 agonists is described. This class of molecules exhibits excellent sst2 potency and selectivity against sst1, sst3, and sst5 receptors, and they are significantly more potent at inhibiting cAMP production than inducing internalization. The orally bioavailable 6-(3-chloro-5-methylphenyl)-3-(3-fluoro-5-hydroxyphenyl)-5-({methyl[(2S)-pyrrolidin-2-ylmethyl]amino}methyl)-3H,4H-pyrido[2,3-d]pyrimidin-4-one (36) also suppresses GH secretion in GHRH-challenged rats in a dose-dependent manner.

CiteXplore: 32805408

DOI: 10.1016/j.bmcl.2020.127496